Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
Kristen A. Clarkson, Robert W. Frenck, Michelle Dickey, et al.
mSphere (2020) Vol. 5, Iss. 5
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
Kristen A. Clarkson, Kawsar R. Talaat, Cristina Alaimo, et al.
EBioMedicine (2021) Vol. 66, pp. 103308-103308
Open Access | Times Cited: 43
Shigella Vaccines: The Continuing Unmet Challenge
Ti Lu, Sayan Das, Debaki Ranjan Howlader, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4329-4329
Open Access | Times Cited: 7
Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
Richard I. Walker, Robert W. Kaminski, Chad K. Porter, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1382-1382
Open Access | Times Cited: 35
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
Francesca Micoli, Omar Rossi, Valentino Conti, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution
K. Ross Turbyfill, Kristen A. Clarkson, Edwin V. Oaks, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 548-548
Open Access | Times Cited: 26
Controlled Human Infection Models To Accelerate Vaccine Development
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 25
Systems approach to define humoral correlates of immunity to Shigella
Biana Bernshtein, Esther Ndungo, Deniz Cizmeci, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111216-111216
Open Access | Times Cited: 25
Recent advances in modelling Shigella infection
Sydney L. Miles, Kathryn E. Holt, Serge Mostowy
Trends in Microbiology (2024) Vol. 32, Iss. 9, pp. 917-924
Open Access | Times Cited: 5
Conserved antigens for enteric vaccines
Richard I. Walker
Vaccine (2025) Vol. 50, pp. 126828-126828
Open Access
Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model
Zachary Liechty, A. S. Baldwin, Sandra D. Isidean, et al.
mSphere (2025)
Open Access
Functional assays to evaluate antibody-mediated responses against Shigella: a review
Elena Boero, Giacomo Vezzani, Francesca Micoli, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Vaccine value profile for Shigella
William P. Hausdorff, John Anderson, Karoun H. Bagamian, et al.
Vaccine (2023) Vol. 41, pp. S76-S94
Open Access | Times Cited: 11
A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes
Girmay Desalegn, Neeraj Kapoor, Lucy Pill-Pepe, et al.
mSphere (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 10
Exploring Natural Immune Responses to Shigella Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study
Prisca Benedicto-Matambo, Lindsay Avolio, Henry Badji, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. Supplement_1, pp. S58-S64
Open Access | Times Cited: 3
Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function
Biana Bernshtein, Meagan Kelly, Deniz Cizmeci, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 10, pp. 100889-100889
Open Access | Times Cited: 3
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine
Valentino Conti, Omar Rossi, Kristen A. Clarkson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
Robert W. Frenck, Michelle Dickey, Akamol E. Suvarnapunya, et al.
mSphere (2020) Vol. 5, Iss. 5
Open Access | Times Cited: 20
Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, et al.
mSphere (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 15
Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children
Protim Sarker, Akhirunnesa Mily, Anjuman Ara, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_7, pp. S829-S839
Open Access | Times Cited: 14
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (Invaplex AR ) vaccines
K. Ross Turbyfill, Kristen A. Clarkson, Edwin V. Oaks, et al.
mSphere (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 5
Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions
Timothy A. Scott, Kate S. Baker, Caroline Trotter, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers
Christopher Duplessis, Kristen A. Clarkson, K. Ross Turbyfill, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6261-6271
Open Access | Times Cited: 4
Controlled human infectious models, a path forward in uncovering immunological correlates of protection: Lessons from enteric fevers studies
Marcelo B. Sztein, Jayaum S. Booth
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 6
Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta)
Dilara Islam, Nattaya Ruamsap, Rawiwan Im‐Erbsin, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0294021-e0294021
Open Access | Times Cited: 3
Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding
Malabi M. Venkatesan, Cassandra Ballou, Shoshana Barnoy, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0259361-e0259361
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top